Hermetica Superfood Encyclopedia
The Short Answer
Myristica fragrans seeds contain phenylpropanoid compounds—primarily myristicin (up to 13.39%), elemicin (up to 24.44%), eugenol, and sabinene—alongside the lignan macelignan, which exert antioxidant, enzyme-inhibitory, antimicrobial, and hepatoprotective effects through radical scavenging, cholinesterase inhibition, and membrane disruption. Evidence supporting these bioactivities derives exclusively from in vitro and animal models; no human clinical trials with quantified effect sizes have been completed, limiting current therapeutic conclusions.
CategoryHerb
GroupSoutheast Asian
Evidence LevelPreliminary
Primary Keywordnutmeg health benefits
Nutmeg — botanical close-up
Health Benefits
**Enzyme Inhibition for Cognitive Support**
Spent seed extracts inhibit butyrylcholinesterase (up to 4.78 mg GALAE/g) and acetylcholinesterase (4.04–4.61 mg GALAE/g) in vitro, suggesting a mechanism relevant to neuroprotection by increasing acetylcholine availability, analogous to approved dementia pharmacotherapies.
**Antioxidant Activity**: Phenolic-rich spent seed extracts containing 63
31 ± 0.72 mg GAE/g total phenolics and 8.31 ± 0.06 mg RE/g flavonoids exhibit significant free-radical scavenging and metal-reduction capacity, potentially mitigating oxidative stress-driven cellular damage.
**Antimicrobial Properties**
Essential oil components—particularly elemicin, eugenol, and myristicin—disrupt microbial cell membranes and inhibit bacterial and fungal growth in preclinical assays, supporting the traditional use of nutmeg in preserving food and treating infections.
**Glycemic Management Potential**: Extracts inhibit α-amylase (0
16–0.44 mmol ACAE/g) and α-glucosidase (1.69–1.90 mmol ACAE/g), enzymes critical to postprandial glucose absorption, pointing to a possible adjunctive role in glycemic control pending human validation.
**Hepatoprotective Effects**
Ayurvedic and preclinical data attribute liver-protective properties to nutmeg's phenylpropanoids and lignans, with animal models suggesting attenuation of hepatotoxin-induced liver injury, though clinical hepatoprotection is unestablished.
**Skin Pigmentation Modulation**: Seed extracts inhibit tyrosinase activity (16
16–61.79 mg KAE/g in vitro), a rate-limiting enzyme in melanin biosynthesis, suggesting cosmetic or dermatological utility for hyperpigmentation management.
**Analgesic and Gastrointestinal Relief**
Traditional Malay medicine employs nutmeg preparations topically and orally for pain relief and stomach ailments; these uses are plausibly linked to eugenol's known COX-inhibitory and carminative properties, though direct clinical verification is lacking.
Origin & History
Natural habitat
Myristica fragrans is native to the Banda Islands of the Maluku (Moluccas) archipelago in eastern Indonesia, thriving in humid tropical climates with well-drained volcanic soils at low to moderate elevations. The tree produces two distinct spice products: the seed kernel (nutmeg) and the dried red aril surrounding the seed (mace), both harvested from the same fruit. Commercial cultivation has expanded to Grenada, Sri Lanka, India (Kerala), and Malaysia, with Indonesia and Grenada remaining the dominant global producers.
“Nutmeg was among the most economically and geopolitically significant spices of the 15th–17th centuries, driving European colonial ventures into the Banda Islands and prompting the Dutch East India Company (VOC) to establish violent monopolistic control over its trade by the early 1600s. In Malay traditional medicine (perubatan Melayu), nutmeg preparations—including oil-based topical rubs and oral decoctions—have long been prescribed for rheumatic pain, flatulence, diarrhea, and as a general tonic, with the kernel and mace used interchangeably in many formulas. Ayurvedic texts reference Myristica fragrans (Jatiphala) for its digestive, hepatoprotective, and aphrodisiac properties, recommending small seed-powder doses combined with honey or ghee. The hallucinogenic properties of large nutmeg doses were documented in European medical literature as early as the 12th century (Hildegard von Bingen), and intoxication cases from excessive consumption have been recorded in clinical literature since the 19th century.”Traditional Medicine
Scientific Research
The totality of published evidence for Myristica fragrans bioactivities rests on in vitro assays and animal experiments; no registered randomized controlled trials in human subjects have been identified in the available literature, constraining the clinical applicability of findings. GC-MS compositional studies have reliably characterized volatile profiles across seed, mace, kernel, and leaf fractions, with inter-study variation in compound rankings (e.g., elemicin-dominant vs. sabinene-dominant profiles) attributable to geographic origin, harvest stage, and extraction method. Enzyme inhibition studies using spent seed and n-hexane extracts report reproducible IC₅₀ and GALAE/KAE equivalent values, but these preclinical metrics do not translate directly to effective human doses without pharmacokinetic data. Hepatoprotective and anticancer claims, while repeated across review literature, lack dose–response characterization in mammalian models sufficient to establish mechanistic pathways such as specific apoptosis induction, NF-κB modulation, or ROS normalization.
Preparation & Dosage
Traditional preparation
**Culinary Spice (Ground Seed)**
25–1 g per serving in food; this dose is generally regarded as safe and is the predominant global mode of human exposure
Typically 0..
**Essential Oil (Steam-Distilled)**
Yields 0.3–12.5% from seed and 8.1–10.3% from mace; used topically in aromatherapy at 1–3% dilution in carrier oil; oral medicinal use is not standardized.
**Seed n-Hexane Extract**
31 mg GAE/g in research preparations
Used in preclinical studies; no human dose established; total phenolics standardized to 63..
**Mace Extract**
Essential oil yield 8.1–10.3%; richer in myristicin and monoterpenes than seed oil; no clinical dose range validated.
**Traditional Malay/Ayurvedic Decoction**
5–1 g) suspended in warm water or milk, consumed for stomach complaints or as a sleep aid; preparations are empirical and not standardized
Small amounts of ground nutmeg (approximately 0..
**Standardized Supplements**
No commercially standardized capsule or tablet formulation with validated bioactive percentages exists; products marketed with myristicin content should be used with extreme caution given narrow therapeutic-to-toxic ratio.
**Timing**
Culinary use is unrestricted; medicinal preparations traditionally taken with meals to reduce gastric irritation.
Nutritional Profile
Ground nutmeg seed (per 100 g) provides approximately 525 kcal, 36 g fat (predominantly myristic acid, oleic acid, and palmitic acid), 49 g total carbohydrate (with ~21 g dietary fiber), and 6 g protein. Micronutrient content is notable for manganese (~17 mg, >700% DV), copper (~1.1 mg), magnesium (~183 mg), phosphorus (~213 mg), and zinc (~2.2 mg). Phytochemical fractions include volatile essential oil (4–16% of dry seed weight) dominated by sabinene, α-pinene, β-pinene, and myristicin; non-volatile phenolics include macelignan, malabaricone C, trimyristin (45–55% of fixed oil), and flavonoid glycosides. Bioavailability of fat-soluble terpenoids and phenylpropanoids is enhanced by the naturally high fixed-oil content of the seed matrix, though first-pass hepatic metabolism of myristicin significantly limits systemic exposure at culinary doses.
How It Works
Mechanism of Action
The primary bioactive compounds—myristicin, elemicin, eugenol, sabinene, and the lignan macelignan—act through complementary molecular mechanisms: eugenol inhibits cyclooxygenase enzymes and disrupts bacterial phospholipid bilayers, contributing to analgesic and antimicrobial effects, while myristicin undergoes metabolic conversion to amphetamine-like metabolites at toxic doses and modulates monoamine oxidase at pharmacological concentrations. Elemicin and other phenylpropanoids scavenge reactive oxygen species and reduce Fe³⁺ to Fe²⁺ in FRAP assays, demonstrating direct antioxidant capacity via electron donation. Acetylcholinesterase and butyrylcholinesterase inhibition by seed polyphenols may involve hydrogen bonding and hydrophobic interactions within the enzyme's active gorge, extending the half-life of acetylcholine in synaptic clefts. Amylase and glucosidase inhibition likely proceeds through competitive binding at substrate-recognition sites, slowing carbohydrate hydrolysis and attenuating postprandial hyperglycemia in preclinical models.
Clinical Evidence
No published human clinical trials examining Myristica fragrans or its isolated constituents for therapeutic endpoints—including pain, cognition, glycemic control, or liver protection—were identified in the current evidence base. Existing bioactivity data derive entirely from in vitro cell-free and cell-based assays and rodent toxicology or pharmacology studies, which are insufficient to establish human efficacy or safe therapeutic dosing windows. The absence of pharmacokinetic studies in humans means that bioavailability of key compounds such as myristicin, elemicin, and macelignan from oral preparations remains uncharacterized. Confidence in the therapeutic utility of nutmeg-derived products for any clinical indication must therefore be rated as very low until appropriately powered human trials are conducted.
Safety & Interactions
At culinary doses (under 1–2 g ground nutmeg), Myristica fragrans is generally recognized as safe (GRAS) by the FDA; however, doses exceeding 5 g in a single administration have caused acute toxicity characterized by tachycardia, hallucinations, nausea, dry mouth, and CNS depression, attributable primarily to myristicin's monoamine-oxidase-inhibitory and amphetamine-precursor properties and to safrole's genotoxic and carcinogenic potential at high chronic exposures. Safrole is classified as a possible human carcinogen (IARC Group 2B) and its presence in essential oil preparations warrants caution with long-term medicinal use beyond culinary amounts. Potential drug interactions include additive CNS depression with sedatives, opioids, and antidepressants due to MAO inhibitory activity of myristicin; co-administration with anticoagulants (warfarin) deserves caution as eugenol inhibits platelet aggregation. Nutmeg preparations are contraindicated in pregnancy at doses above culinary levels due to potential uterotonic and teratogenic effects of myristicin and safrole; hepatically impaired individuals should also avoid concentrated extracts given the hepatotoxic risk at high doses identified in animal studies.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Myristica fragrans Houtt.Jatiphala (Ayurveda)Buah Pala (Malay)Moscato (Italian)Jaiphal (Hindi)Muskaatnoot (Dutch)
Frequently Asked Questions
What are the main active compounds in nutmeg and what do they do?
The primary bioactive compounds in Myristica fragrans seed include myristicin (up to 13.39% of volatile oil), elemicin (up to 24.44%), eugenol, sabinene, and the lignan macelignan. Myristicin inhibits monoamine oxidase and can modulate neurotransmitter levels; eugenol inhibits cyclooxygenase enzymes for analgesic and anti-inflammatory effects; and macelignan has demonstrated antimicrobial and neuroprotective activity in preclinical assays. Together these compounds also inhibit cholinesterase enzymes and exhibit antioxidant activity, though all evidence comes from laboratory models, not human trials.
Is nutmeg safe to take as a supplement or in large amounts?
Nutmeg is safe at typical culinary doses of under 1–2 grams, but doses above approximately 5 grams in a single sitting can cause serious acute toxicity, including hallucinations, tachycardia, nausea, dry mouth, and prolonged CNS depression. This toxicity is driven by myristicin acting as a monoamine oxidase inhibitor and partial amphetamine precursor, and by safrole, classified as a potential carcinogen (IARC Group 2B). No standardized medicinal supplement dose has been validated in human trials, so concentrated nutmeg extracts or essential oil capsules should be approached with caution.
Does nutmeg help with sleep or anxiety?
Nutmeg has a traditional reputation as a mild sedative in Ayurvedic and Malay medicine, with small pinches of ground nutmeg in warm milk historically prescribed for insomnia. The proposed mechanism involves myristicin's monoamine oxidase inhibitory activity, which may elevate serotonin levels, and the general CNS-depressant effects seen at higher doses in animal studies. However, no randomized controlled trials in humans have evaluated nutmeg for sleep quality or anxiety endpoints, so this use remains supported only by traditional practice and anecdotal reports.
Can nutmeg help with blood sugar or diabetes?
In vitro studies show that Myristica fragrans seed extracts inhibit the carbohydrate-digesting enzymes α-amylase (0.16–0.44 mmol ACAE/g) and α-glucosidase (1.69–1.90 mmol ACAE/g), which could theoretically slow postprandial glucose absorption. This enzyme-inhibitory mechanism is similar to that of the approved antidiabetic drug acarbose, making nutmeg a candidate for further research. However, no human clinical trials have tested nutmeg's effect on blood glucose, HbA1c, or insulin sensitivity, so it cannot currently be recommended as a diabetes management tool.
Does nutmeg interact with any medications?
Nutmeg contains myristicin, a compound with monoamine oxidase inhibitory (MAOI) properties, which could interact with antidepressants—particularly SSRIs, SNRIs, or other MAOIs—raising the risk of serotonin syndrome at medicinal doses. Eugenol inhibits platelet aggregation, meaning concentrated nutmeg preparations may potentiate the effects of anticoagulants such as warfarin and increase bleeding risk. At large doses, nutmeg's general CNS-depressant profile could also amplify sedation from opioids, benzodiazepines, and alcohol; culinary use is unlikely to produce significant interactions, but medicinal extracts warrant medical supervision.
What does research show about nutmeg's effects on memory and cognitive function?
Nutmeg seed extracts have demonstrated in vitro inhibition of acetylcholinesterase and butyrylcholinesterase enzymes, which are the same targets as FDA-approved dementia medications like donepezil. By increasing acetylcholine availability in the brain, this mechanism suggests neuroprotective potential, though human clinical trials are limited and more research is needed to establish efficacy and effective dosages. The phenolic compounds responsible for this activity are found in higher concentrations in nutmeg spent seed extracts used in research models.
How does nutmeg compare to other herbal nootropics for brain health?
Unlike some herbal nootropics that primarily work through antioxidant pathways, nutmeg offers a dual mechanism combining acetylcholinesterase inhibition (directly targeting neurotransmitter levels) with antioxidant activity from its phenolic compounds. This combination is similar to how prescription cognitive enhancers work, though nutmeg's effects are generally milder and require more human research for validation. Other herbal options like ginkgo biloba and bacopa share antioxidant properties but differ in their specific enzymatic targets and clinical evidence strength.
What is the difference between whole nutmeg, nutmeg extract, and spent seed extract for supplementation?
Whole nutmeg powder contains active compounds but with variable concentrations, while concentrated extracts standardize levels of beneficial phenolics and volatile oils for consistent dosing. Spent seed extracts—the byproduct remaining after essential oil extraction—have been specifically studied for superior acetylcholinesterase inhibition (4.04–4.61 mg GALAE/g) and show higher polyphenol content (63.31 mg GAE/g) compared to whole seed. For maximum bioavailability of enzyme-inhibiting compounds relevant to cognitive support, standardized extracts are generally preferred over whole nutmeg, though research on human absorption remains limited.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w nutmeg-myristica-fragrans curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
